# Hyperfine, Inc.: filings

HYPR · Nasdaq · CIK 1833769 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hypr.md) · [Financials](/companies/hypr/financials.md) · [Filings](/companies/hypr/filings.md) · [Insiders](/companies/hypr/insiders.md)

## Reports and events: 104 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 107, 8-K 68, 3 24, 425 23, 424B3 20, 10-Q 17, 4/A 11, CORRESP 9, UPLOAD 8, EFFECT 7, 10-K 6, 424B5 6, DEF 14A 5, DEFA14A 5, S-8 5, ARS 4, S-4/A 4, SC 13G 3, SC 13G/A 3, 3/A 2, 8-K/A 2, DRS 2, NT 10-Q 2, POS AM 2, PRE 14A 2, S-1 2, S-1/A 2, S-3 2, SEC STAFF LETTER 2, 424B4 1, 8-A12B 1, CERT 1, DEF 14C 1, PRE 14C 1, S-1MEF 1, S-4 1, S-4MEF 1, SC 13D 1, SC 13D/A 1, SCHEDULE 13G/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-08 | 11:40 ET | [8-K](/filings/0001193125-26-417437.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-417437 |
| 2026-09-18 | 20:07 ET | [8-K](/filings/0001193125-26-395525.md) | 3.01 Delisting notice | 0001193125-26-395525 |
| 2026-08-06 | 20:11 ET | [10-Q](/filings/0001193125-26-338015.md) | Quarterly report, period 2026-06-30 | 0001193125-26-338015 |
| 2026-08-06 | 20:05 ET | [8-K](/filings/0001193125-26-337963.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-337963 |
| 2026-05-21 | 20:11 ET | [8-K](/filings/0001193125-26-234426.md) | 5.07 Shareholder vote results | 0001193125-26-234426 |
| 2026-05-12 | 20:11 ET | [10-Q](/filings/0001193125-26-219428.md) | Quarterly report, period 2026-03-31 | 0001193125-26-219428 |
| 2026-05-12 | 20:06 ET | [8-K](/filings/0001193125-26-219380.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-219380 |
| 2026-04-08 | 20:10 ET | [DEF 14A](/filings/0001193125-26-147623.md) | Proxy statement, period 2026-05-21 | 0001193125-26-147623 |
| 2026-03-18 | 20:21 ET | [10-K](/filings/0001193125-26-114044.md) | Annual report, period 2025-12-31 | 0001193125-26-114044 |
| 2026-03-18 | 20:15 ET | [8-K](/filings/0001193125-26-113996.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-26-113996 |
| 2026-03-18 | 20:10 ET | [8-K](/filings/0001193125-26-113960.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-113960 |
| 2026-01-12 | 13:28 ET | [8-K](/filings/0001193125-26-009859.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-009859 |
| 2025-12-29 | 21:17 ET | [8-K](/filings/0001193125-25-335370.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-335370 |
| 2025-11-13 | 21:17 ET | [10-Q](/filings/0001193125-25-280212.md) | Quarterly report, period 2025-09-30 | 0001193125-25-280212 |
| 2025-11-13 | 21:11 ET | [8-K](/filings/0001193125-25-280181.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-280181 |
| 2025-10-16 | 20:18 ET | [8-K](/filings/0001193125-25-241438.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-241438 |
| 2025-10-15 | 20:09 ET | [8-K](/filings/0001193125-25-240255.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-240255 |
| 2025-08-13 | 20:15 ET | [10-Q](/filings/0000950170-25-108047.md) | Quarterly report, period 2025-06-30 | 0000950170-25-108047 |
| 2025-08-13 | 20:10 ET | [8-K](/filings/0000950170-25-108030.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-108030 |
| 2025-08-06 | 20:01 ET | [8-K](/filings/0000950170-25-103970.md) | 8.01 Other events | 0000950170-25-103970 |
| 2025-05-23 | 21:00 ET | [8-K](/filings/0001193125-25-125906.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-125906 |
| 2025-05-19 | 20:15 ET | [8-K](/filings/0000950170-25-074355.md) | 5.07 Shareholder vote results | 0000950170-25-074355 |
| 2025-05-13 | 20:20 ET | [10-Q](/filings/0000950170-25-070402.md) | Quarterly report, period 2025-03-31 | 0000950170-25-070402 |
| 2025-05-13 | 20:10 ET | [8-K](/filings/0000950170-25-070340.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-070340 |
| 2025-05-02 | 20:08 ET | [8-K](/filings/0000950170-25-062762.md) | 3.01 Delisting notice | 0000950170-25-062762 |
| 2025-04-07 | 20:05 ET | [DEF 14A](/filings/0001193125-25-074640.md) | Proxy statement, period 2025-05-19 | 0001193125-25-074640 |
| 2025-03-17 | 20:15 ET | [10-K](/filings/0000950170-25-040281.md) | Annual report, period 2024-12-31 | 0000950170-25-040281 |
| 2025-03-17 | 20:10 ET | [8-K](/filings/0000950170-25-040251.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-040251 |
| 2025-02-11 | 21:18 ET | [8-K](/filings/0001193125-25-024326.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-024326 |
| 2025-02-11 | 13:00 ET | [8-K](/filings/0001193125-25-023996.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-023996 |
| 2025-01-29 | 14:00 ET | [8-K](/filings/0000950170-25-010230.md) | 2.05 Exit or disposal costs | 0000950170-25-010230 |
| 2024-11-12 | 22:00 ET | [10-Q](/filings/0000950170-24-125624.md) | Quarterly report, period 2024-09-30 | 0000950170-24-125624 |
| 2024-11-12 | 21:15 ET | [8-K](/filings/0000950170-24-125433.md) | 2.02 Results of operations | 0000950170-24-125433 |
| 2024-08-09 | 20:01 ET | [10-Q](/filings/0000950170-24-094720.md) | Quarterly report, period 2024-06-30 | 0000950170-24-094720 |
| 2024-08-08 | 20:11 ET | [8-K](/filings/0000950170-24-093965.md) | 2.02 Results of operations | 0000950170-24-093965 |
| 2024-07-24 | 20:15 ET | [8-K](/filings/0000950170-24-086057.md) | 8.01 Other events | 0000950170-24-086057 |
| 2024-06-12 | 20:04 ET | [8-K](/filings/0000950170-24-072416.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-24-072416 |
| 2024-05-31 | 20:06 ET | [8-K](/filings/0000950170-24-067303.md) | 3.01 Delisting notice | 0000950170-24-067303 |
| 2024-05-14 | 20:01 ET | [10-Q](/filings/0000950170-24-059482.md) | Quarterly report, period 2024-03-31 | 0000950170-24-059482 |
| 2024-05-13 | 20:13 ET | [8-K](/filings/0000950170-24-058664.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-058664 |
| 2024-04-26 | 20:10 ET | [DEF 14A](/filings/0001193125-24-118049.md) | Proxy statement, period 2024-06-11 | 0001193125-24-118049 |
| 2024-03-22 | 20:06 ET | [10-K](/filings/0000950170-24-035343.md) | Annual report, period 2023-12-31 | 0000950170-24-035343 |
| 2024-03-21 | 20:11 ET | [8-K](/filings/0000950170-24-034697.md) | 2.02 Results of operations | 0000950170-24-034697 |
| 2023-11-09 | 21:58 ET | [8-K](/filings/0001193125-23-274593.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-23-274593 |
| 2023-11-09 | 21:14 ET | [10-Q](/filings/0000950170-23-062066.md) | Quarterly report, period 2023-09-30 | 0000950170-23-062066 |
| 2023-11-09 | 21:10 ET | [8-K](/filings/0000950170-23-062049.md) | 2.02 Results of operations | 0000950170-23-062049 |
| 2023-10-03 | 20:07 ET | [8-K](/filings/0000950170-23-051513.md) | 5.02 Departure or appointment of officers or directors | 0000950170-23-051513 |
| 2023-08-14 | 20:16 ET | [10-Q](/filings/0000950170-23-042430.md) | Quarterly report, period 2023-06-30 | 0000950170-23-042430 |
| 2023-08-14 | 20:11 ET | [8-K](/filings/0000950170-23-042415.md) | 2.02 Results of operations | 0000950170-23-042415 |
| 2023-07-18 | 20:19 ET | [8-K](/filings/0000950170-23-033349.md) | 5.02 Departure or appointment of officers or directors | 0000950170-23-033349 |

Page 1 of 3. [Older](/companies/hypr/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.